Gabriel Chamie, MD

Associate Professor

Gabriel Chamie, MD, MPH is an Associate Professor of Medicine and a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at the University of California, San Francisco (UCSF). Dr. Chamie has been conducting HIV and TB clinical and epidemiological research in sub-Saharan Africa since 2008. His research interests include community-based HIV and tuberculosis (TB) diagnosis, TB/HIV co-infection, and TB transmission dynamics in settings with generalized HIV epidemics. He is a co-investigator in the SEARCH Trial of a “test and treat” approach in East Africa, and currently serves as Chair of the SEARCH Trial HIV Testing Working Group implementing large-scale, multi-disease community health campaigns and population-wide HIV testing. He is also co-Principal Investigator of the IBIS-Health study, investigating novel incentive approaches to increase HIV testing among men in rural Uganda. He has an active clinical practice in HIV and TB clinics at San Francisco General Hospital.
Fellowship, 06/2011 - AIDS Prevention Studies, Center for AIDS Prevention Studies, University of California, San Francisco
Fellowship, 06/2011 - Infectious Diseases, University of California, San Francisco
MPH, 05/2009 - Epidemiology, University of California, Berkeley
Residency, 06/2006 - Internal Medicine, University of California, San Francisco
MD, 05/2003 - Medicine, Stanford Medical School
BA, 05/1998 - History, Yale University
Honors and Awards
  • CFAR Early Career Award of Excellence in Translational Research, UCSF-GIVI, 2013
  • International AIDS Society (IAS)/ANRS Young Investigator’s Award in Clinical Research, International AIDS Society (IAS)/ANRS, 2010
  • The Julius R. Krevans Award for Clinical Excellence, San Francisco General Hospital, UCSF, and the J. David Gladstone Institutes, 2004
  • The Allen B. Barbour Award for Excellence in Clinical Medicine, Stanford Medical School, 2003
  • Berkeley College Master's Prize for distinguished involvement in the Yale and New Haven communities, Yale University, 1998
  1. Universal HIV Testing and Treatment (UTT) Integrated with Chronic Disease Screening and Treatment: the SEARCH study.
  2. Promoting HIV Testing by Men: A Discrete Choice Experiment to Elicit Preferences and Predict Uptake of Community-based Testing in Uganda.
  3. SARS-CoV-2 PCR and antibody testing for an entire rural community: methods and feasibility of high-throughput testing procedures.
  4. A pilot randomized trial of incentive strategies to promote HIV retesting in rural Uganda.
  5. Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
  6. Far from MCAR: Obtaining population-level estimates of HIV viral suppression.
  7. Higher levels of alcohol use are associated with latent tuberculosis infection in adults living with HIV.
  8. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa.
  9. Men's Beliefs About the Likelihood of Serodiscordance in Couples with an HIV-Positive Partner: Survey Evidence from Rural Uganda.
  10. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study.
  11. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
  12. The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda.
  13. Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation.
  14. The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda.
  15. Leveraging incentives to increase HIV testing uptake among men: qualitative insights from rural Uganda.
  16. Machine learning to identify persons at high-risk of HIV acquisition in rural Kenya and Uganda.
  17. Reaching 90-90-90 in rural communities in East Africa: lessons from the Sustainable East Africa Research in Community Health Trial.
  18. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa.
  19. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.
  20. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study.
  21. Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial.
  22. Mobile, Population-Wide, Hybrid HIV Testing Strategy Increases Number of Children Tested in Rural Kenya and Uganda.
  23. Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16.
  24. Spatial overlap links seemingly unconnected genotype-matched TB cases in rural Uganda.
  25. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
  26. Gaps in the Child Tuberculosis Care Cascade in 32 Rural Communities in Uganda and Kenya.
  27. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya.
  28. Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa.
  29. Population levels and geographical distribution of HIV RNA in rural Ugandan and Kenyan communities, including serodiscordant couples: a cross-sectional analysis.
  30. High levels of retention in care with streamlined care and universal test and treat in East Africa.
  31. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa.
  32. Implementation and Operational Research: Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda.
  33. Increased adolescent HIV testing with a hybrid mobile strategy in Uganda and Kenya.
  34. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda.
  35. Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda.
  36. A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational study.
  37. Men "missing" from population-based HIV testing: insights from qualitative research.
  38. Authors' response.
  39. Identifying locations of recent TB transmission in rural Uganda: a multidisciplinary approach.
  40. Testosterone replacement therapy among HIV-infected men in the CFAR Network of Integrated Clinical Systems.
  41. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/µl in rural Uganda.
  42. Assessing the quality of tuberculosis evaluation for children with prolonged cough presenting to routine community health care settings in rural Uganda.
  43. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration.
  44. HIV-associated central nervous system tuberculosis.
  45. Changes in population HIV RNA levels in Mbarara, Uganda, during scale-up of HIV antiretroviral therapy access.
  46. Evaluating linkage to care for hypertension after community-based screening in rural Uganda.
  47. Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda.
  48. Epidemiology and awareness of hypertension in a rural Ugandan community: a cross-sectional study.
  49. High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/µL under routine program conditions in Uganda.
  50. Household ventilation and tuberculosis transmission in Kampala, Uganda.
  51. Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda.
  52. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method.
  53. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda.
  54. Tuberculosis drug development: ensuring people living with HIV are not left behind.
  55. Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata.
  56. Mycobacterium tuberculosis microbiologic and clinical treatment outcomes in a randomized trial of immediate versus CD4(+)-initiated antiretroviral therapy in HIV-infected adults with a high CD4(+) cell count.
  57. Tuberculosis as part of the natural history of HIV infection in developing countries.
  58. Streptococcus pneumoniae keratitis.
  59. Factors associated with seronegative chronic hepatitis C virus infection in HIV infection.